Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematologic Malignancies
•
Radiation Oncology
•
Medical Oncology
•
Myeloma
•
Hematology
What radiation doses and subsequent treatment monitoring would you recommend for multiple myeloma patients with multifocal bony lesions and decline chemotherapy?
Related Questions
How do you approach the second-line treatment for a patient with high-risk myeloma relapse early post-autoHCT after Dara-RVD induction?
In a patient with cardiac light chain amyloid who has significant heart failure symptoms, including inotrope dependence at presentation, how much clinical benefit does treatment provide?
What is your re-immunization strategy after auto SCT for patients with myeloma on dara/len maintenance?
How would you approach management and monitoring of AL amyloidosis with isolated renal involvement?
Could patients with smIPI > 1 and poor tolerability to RCHOP be offered ISRT after 3 cycles of RCHOP if interim PET showed 5-PS 1-3 response?
What is your preferred dose and schedule for maintenance drugs post autoHCT for newly diagnosed multiple myeloma?
What is your approach to bone imaging in MGUS?
How would you treat a stage I fully resected double hit DLBCL?
What is your approach to management of relapsed/refractory T-cell prolymphocytic leukemia (T-PLL)?
For biopsy proven extranodal marginal zone lymphoma involving two small bilateral lung nodules, would you consider definitive treatment to both nodules with radiation therapy?
